To address this issue we correlated amphiregulin expression levels with the Cisplatin resistant state of a collection of human breast cancer cells and found a correlation which demonstrates that breast cancer cells use amphiregulin as a survival signal to resist exposure to Cisplatin [64]. This evidence concerns the gene AREG and breast carcinoma.